MYLIFE Trial
Cross-source consensus on MYLIFE Trial from 1 sources and 4 claims.
1 sources · 4 claims
Benefits
Comparisons
Other
Highlighted claims
- MYLIFE is a three-arm cluster-randomised controlled trial targeting metabolic syndrome risk reduction among employed adults in China. — mHealth-based Healthy Lifestyle Promotion (MYLIFE) for metabolic syndrome risk reduction in Chinese employed adults: protocol for a cluster-randomised controlled trial
- The intervention lasts 12 weeks and the total follow-up period lasts 1 year. — mHealth-based Healthy Lifestyle Promotion (MYLIFE) for metabolic syndrome risk reduction in Chinese employed adults: protocol for a cluster-randomised controlled trial
- MYLIFE compares routine health management with smartphone-only and stratified smartphone-plus-wearable mHealth strategies. — mHealth-based Healthy Lifestyle Promotion (MYLIFE) for metabolic syndrome risk reduction in Chinese employed adults: protocol for a cluster-randomised controlled trial
- The trial is hypothesised to reduce metabolic syndrome risk more in intervention groups than in the control group at the primary endpoint. — mHealth-based Healthy Lifestyle Promotion (MYLIFE) for metabolic syndrome risk reduction in Chinese employed adults: protocol for a cluster-randomised controlled trial